Regenerative Medical Technology Group Inc. (RMTG)
OTCMKTS · Delayed Price · Currency is USD
0.0300
+0.0020 (7.14%)
Aug 1, 2025, 4:00 PM EDT
RMTG Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 4.65 | 4.11 | 2.41 | 1.53 | 0.44 | 0.06 | Upgrade | |
Revenue Growth (YoY) | 90.71% | 70.44% | 57.49% | 249.46% | 694.97% | 82.98% | Upgrade |
Cost of Revenue | 1.46 | 1.28 | 0.73 | 0.65 | 0.29 | 0.04 | Upgrade |
Gross Profit | 3.2 | 2.82 | 1.68 | 0.88 | 0.15 | 0.01 | Upgrade |
Selling, General & Admin | 2.65 | 2.47 | 2.07 | 1.72 | 9.93 | 0.45 | Upgrade |
Operating Expenses | 2.85 | 2.69 | 2.38 | 1.87 | 9.97 | 0.45 | Upgrade |
Operating Income | 0.35 | 0.13 | -0.71 | -0.99 | -9.82 | -0.44 | Upgrade |
Interest Expense | -4.68 | -5.64 | -6.49 | -4.4 | -2.72 | -4.2 | Upgrade |
Other Non Operating Income (Expenses) | -0.03 | -0.05 | -0 | -0.18 | -0.1 | -1.25 | Upgrade |
EBT Excluding Unusual Items | -4.36 | -5.56 | -7.2 | -5.58 | -12.64 | -5.89 | Upgrade |
Impairment of Goodwill | - | - | -4.13 | - | - | - | Upgrade |
Legal Settlements | - | - | - | - | -0.23 | - | Upgrade |
Other Unusual Items | - | - | 1.51 | - | - | -0.01 | Upgrade |
Pretax Income | -4.36 | -5.56 | -9.81 | -5.58 | -12.87 | -5.9 | Upgrade |
Earnings From Continuing Operations | -4.36 | -5.56 | -9.81 | -5.58 | -12.87 | -5.9 | Upgrade |
Earnings From Discontinued Operations | - | - | - | 0.07 | -0.01 | - | Upgrade |
Net Income | -4.36 | -5.56 | -9.81 | -5.51 | -12.88 | -5.9 | Upgrade |
Net Income to Common | -4.36 | -5.56 | -9.81 | -5.51 | -12.88 | -5.9 | Upgrade |
Shares Outstanding (Basic) | 13 | 13 | 12 | 12 | 11 | 9 | Upgrade |
Shares Outstanding (Diluted) | 13 | 13 | 12 | 12 | 11 | 9 | Upgrade |
Shares Change (YoY) | 0.67% | 0.68% | 1.86% | 6.42% | 22.91% | 76.09% | Upgrade |
EPS (Basic) | -0.35 | -0.44 | -0.79 | -0.45 | -1.12 | -0.63 | Upgrade |
EPS (Diluted) | -0.35 | -0.44 | -0.79 | -0.45 | -1.12 | -0.63 | Upgrade |
Free Cash Flow | 0.64 | 0.64 | -0.8 | -1.31 | -9.88 | -0.32 | Upgrade |
Free Cash Flow Per Share | 0.05 | 0.05 | -0.07 | -0.11 | -0.86 | -0.04 | Upgrade |
Gross Margin | 68.70% | 68.73% | 69.53% | 57.31% | 34.29% | 20.20% | Upgrade |
Operating Margin | 7.52% | 3.25% | -29.30% | -64.99% | -2242.37% | -791.53% | Upgrade |
Profit Margin | -93.71% | -135.44% | -407.21% | -359.87% | -2942.42% | -10703.47% | Upgrade |
Free Cash Flow Margin | 13.83% | 15.47% | -33.40% | -85.78% | -2255.99% | -585.94% | Upgrade |
EBITDA | 0.55 | 0.35 | -0.4 | -0.84 | -9.78 | -0.44 | Upgrade |
EBITDA Margin | 11.73% | 8.62% | -16.44% | -55.01% | - | - | Upgrade |
D&A For EBITDA | 0.2 | 0.22 | 0.31 | 0.15 | 0.04 | 0 | Upgrade |
EBIT | 0.35 | 0.13 | -0.71 | -0.99 | -9.82 | -0.44 | Upgrade |
EBIT Margin | 7.52% | 3.25% | -29.30% | -64.99% | - | - | Upgrade |
Advertising Expenses | - | 0.46 | 0.48 | 0.32 | 0.13 | 0 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.